Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – October 13, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) a pharmaceutical...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – October 6, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) a pharmaceutical...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – September 21, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) a pharmaceutical...
A 4-year-old intact male border collie dog with a body weight of 22 kg was suffering from refractory idiopathic (drug-resistant) epilepsy The dog was frequently hospitalized...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – September 6, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) a pharmaceutical...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – August 30, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased...
6 dogs suffering from osteoarthritis and lameness demonstrated CBD concentrations 6 weeks after a single injection Pain and well-being scores improved following treatment Herzliya, Israel and...
First results from a study on dogs showed close to 100% bioavailability of CBD using Innocan’s LPT technology This is compared to 6.5-20% bioavailability in humans...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – August 5, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – July 29, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased...